Performed an exhaustive desk research on the Zavicefta and Hospital & Ventilator Acquired Pneumonia (HAP|VAP), Complicated Urinary track infection (cUTI)|Pyelonephritis and Complicated Intra-Abdominal Infection (cIAI).
Referred multiple sources like USA FDA, EMEA, Orange book, clincialtrials.gov, CDC, and others along with open search
Overview, chemical structure, dosage and administration, clinical updates, sales, investments, regulatory updates, etc.
The study aimed to gather deep information on the diseases like cIAI, cUTI & HAP, where our team presented an overview of these diseases, its risk factors, symptoms, diagnosis, treatment strategy & algorithm, economic burden, etc.
Pipeline analysis on investigational agents in Phase 2/3